InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Ocugen, Inc.

OCGN Clue Score52
United States Fiscal year ends December CIK 0001372299
$0.96 -2.24% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.96 −87.57% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.0Operating income−30.3Net income−16.2EPS, diluted−2.18Fiscal year 2017Revenue0.0Operating income−25.0Net income−26.4EPS, diluted−0.99Fiscal year 2018Revenue0.0Operating income−16.1Net income−18.2EPS, diluted−0.79Fiscal year 2019Revenue0.0Operating income−14.2Net income−20.2EPS, diluted−1.46Fiscal year 2020Revenue0.0Operating income−21.3Net income−21.8EPS, diluted−0.31Fiscal year 2021Revenue0.0 −100.0%Operating income−58.0Net income−58.4EPS, diluted−0.30Fiscal year 2022Revenue2.5Operating income−89.1Net income−86.8EPS, diluted−0.40Fiscal year 2023Revenue6.0 +142.6%Operating income−65.5Net income−63.1EPS, diluted−0.26Fiscal year 2024Revenue4.1 −32.8%Operating income−54.8Net income−54.1Fiscal year 2025Revenue4.4 +8.8%Operating income−62.9Net income−67.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.0 0.0 0.0 0.0 0.0 0.0 2.5 6.0 4.1 4.4
Growth −100.0% +142.6% −32.8% +8.8%
Operating income −30.3 −25.0 −16.1 −14.2 −21.3 −58.0 −89.1 −65.5 −54.8 −62.9
Net income −16.2 −26.4 −18.2 −20.2 −21.8 −58.4 −86.8 −63.1 −54.1 −67.8
Growth
EPS, diluted −2.18 −0.99 −0.79 −1.46 −0.31 −0.30 −0.40 −0.26 n/a n/a

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2018Fiscal year 2019Fiscal year 2020Operating margin−49,500.0%Net margin−50,748.8%Free cash flow margin−34,920.9%Fiscal year 2021Fiscal year 2022Operating margin−3,580.0%Net margin−3,488.9%Free cash flow margin−2,593.9%Fiscal year 2023Operating margin−1,085.7%Net margin−1,045.0%Free cash flow margin−1,201.6%Fiscal year 2024Operating margin−1,350.4%Net margin−1,333.0%Free cash flow margin−1,122.7%Fiscal year 2025Operating margin−1,425.7%Net margin−1,537.4%Free cash flow margin−1,295.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a n/a −49,500.0% n/a −3,580.0% −1,085.7% −1,350.4% −1,425.7%
Net margin n/a n/a n/a n/a −50,748.8% n/a −3,488.9% −1,045.0% −1,333.0% −1,537.4%
Free cash flow margin n/a n/a n/a n/a −34,920.9% n/a −2,593.9% −1,201.6% −1,122.7% −1,295.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−25.7Capital expenditure−0.3Free cash flow−26.1Fiscal year 2017Operating cash flow−23.0Capital expenditure−0.3Free cash flow−23.3Fiscal year 2018Operating cash flow−11.6Capital expenditure−0.1Free cash flow−11.7Buybacks0.0Fiscal year 2019Operating cash flow−16.9Capital expenditure−0.0Free cash flow−16.9Buybacks−0.0Fiscal year 2020Operating cash flow−14.7Capital expenditure−0.3Free cash flow−15.0Buybacks0.0Fiscal year 2021Operating cash flow−47.9Capital expenditure−0.9Free cash flow−48.9Buybacks0.0Fiscal year 2022Operating cash flow−60.1Capital expenditure−4.5Free cash flow−64.5Fiscal year 2023Operating cash flow−62.1Capital expenditure−10.5Free cash flow−72.5Fiscal year 2024Operating cash flow−42.1Capital expenditure−3.4Free cash flow−45.5Fiscal year 2025Operating cash flow−57.0Capital expenditure−0.2Free cash flow−57.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −25.7 −23.0 −11.6 −16.9 −14.7 −47.9 −60.1 −62.1 −42.1 −57.0
Capital expenditure −0.3 −0.3 −0.1 −0.0 −0.3 −0.9 −4.5 −10.5 −3.4 −0.2
Free cash flow −26.1 −23.3 −11.7 −16.9 −15.0 −48.9 −64.5 −72.5 −45.5 −57.1
Growth
Buybacks n/a n/a 0.0 −0.0 0.0 0.0 n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash31.9Shareholders’ equity13.6Fiscal year 2017Cash7.1Shareholders’ equity4.4Fiscal year 2018Cash1.6Total debt1.0Net cash (debt)0.6Shareholders’ equity−12.7Fiscal year 2019Cash7.4Total debt1.1Net cash (debt)6.4Shareholders’ equity11.0Debt to equity0.10Fiscal year 2020Cash24.0Total debt1.8Net cash (debt)22.2Shareholders’ equity21.6Debt to equity0.08Fiscal year 2021Cash95.0Total debt1.7Net cash (debt)93.2Shareholders’ equity91.2Debt to equity0.02Fiscal year 2022Cash77.6Total debt2.3Net cash (debt)75.3Shareholders’ equity74.0Debt to equity0.03Fiscal year 2023Cash39.5Total debt2.8Net cash (debt)36.7Shareholders’ equity40.6Debt to equity0.07Fiscal year 2024Cash58.8Total debt28.7Net cash (debt)30.2Shareholders’ equity29.6Debt to equity0.97Fiscal year 2025Cash18.6Total debt28.8Net cash (debt)−10.2Shareholders’ equity−12.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 31.9 7.1 1.6 7.4 24.0 95.0 77.6 39.5 58.8 18.6
Total debt n/a n/a 1.0 1.1 1.8 1.7 2.3 2.8 28.7 28.8
Net cash (debt) n/a n/a 0.6 6.4 22.2 93.2 75.3 36.7 30.2 −10.2
Shareholders’ equity 13.6 4.4 −12.7 11.0 21.6 91.2 74.0 40.6 29.6 −12.2
Debt to equity n/a n/a n/a 0.10 0.08 0.02 0.03 0.07 0.97 n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017† 31 Dec 2017 FY2018† 31 Dec 2018 FY2019† 31 Dec 2019 FY2020† 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
0.0 0.0 0.0 0.0 0.0 0.0 2.5 6.0 4.1 4.4
Growth −100.0% +142.6% −32.8% +8.8%
21.6 15.6 10.3 8.1 n/a n/a n/a 39.6 32.1 39.8
8.5 9.4 5.8 6.1 8.0 22.9 35.4 32.0 26.7 27.6
−30.3 −25.0 −16.1 −14.2 −21.3 −58.0 −89.1 −65.5 −54.8 −62.9
Growth
−16.2 −26.4 −8.6 −20.2 −21.8 −58.4 −86.8 −63.1 −54.1 −67.8
n/a n/a n/a 0.0 0.0 −0.1 0.0 0.0 0.0 0.0
−16.2 −26.4 −18.2 −20.2 −21.8 −58.4 −86.8 −63.1 −54.1 −67.8
Growth
Per share
−0.97 −0.99 −0.23 −1.46 −0.31 −0.30 −0.40 −0.26 n/a n/a
−2.18 −0.99 −0.79 −1.46 −0.31 −0.30 −0.40 −0.26 n/a n/a
Growth
14.3 22.7 36.4 13.9 112.2 195.0 214.6 244.3 n/a n/a
14.4 22.7 37.1 13.9 112.2 195.0 214.6 244.3 n/a n/a
Growth +57.5% +63.6% −62.5% +707.8% +73.8% +10.0% +13.9%

† The diluted share count jumps at 2017 and 2018 and 2019 and 2020 and 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 152.5% a year over five years.
  • Operating margin is up 48,074.3 points on five years ago, at -1,425.7%.
  • A net loss in 10 of 10 years on file.